• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    8/14/25 4:16:51 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Centene Corp

    (Name of Issuer)


    Common Stock, $0.001 par value

    (Title of Class of Securities)


    15135B101

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    15135B101


    1Names of Reporting Persons

    HARRIS ASSOCIATES L P
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    18,043,616.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    20,418,731.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    20,418,731.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.1 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    15135B101


    1Names of Reporting Persons

    Harris Associates, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    18,043,616.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    20,418,731.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    20,418,731.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.1 %
    12Type of Reporting Person (See Instructions)

    CO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Centene Corp
    (b)Address of issuer's principal executive offices:

    7700 Forsyth Boulevard, St. Louis, MO, 63105.
    Item 2. 
    (a)Name of person filing:

    Harris Associates L.P. ("Harris") Harris Associates, Inc. ("General Partner") **Harris Associates, Inc., for itself and as General Partner
    (b)Address or principal business office or, if none, residence:

    111 South Wacker Drive Suite 4600, Chicago, IL 60606
    (c)Citizenship:

    See Item 4 on the cover page(s) hereto.
    (d)Title of class of securities:

    Common Stock, $0.001 par value
    (e)CUSIP No.:

    15135B101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    By reason of advisory and other relationships with the person who owns the Shares, Harris may be deemed to be the beneficial owner of the shares specified in Item 9 on the cover page(s) hereto. Harris has been granted the power to vote Shares in circumstances it determines to be appropriate in connection with assisting its advised clients to whom it renders financial advice in the ordinary course of business, by either providing information or advice to the persons having such power, or by exercising the power to vote.
    (b)Percent of class:

    See Item 11 on the cover page(s) hereto.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See Item 5 on the cover page(s) hereto.

     (ii) Shared power to vote or to direct the vote:

    See Item 6 on the cover page(s) hereto.

     (iii) Sole power to dispose or to direct the disposition of:

    See Item 7 on the cover page(s) hereto.

     (iv) Shared power to dispose or to direct the disposition of:

    See Item 8 on the cover page(s) hereto.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    HARRIS ASSOCIATES L P
     
    Signature:Joseph J. Allessie
    Name/Title:Joseph J. Allessie, General Counsel and Secretary
    Date:08/14/2025
     
    Harris Associates, Inc.
     
    Signature:Joseph J. Allessie
    Name/Title:Joseph J. Allessie, General Counsel and Secretary
    Date:08/14/2025
    Get the next $CNC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    7/2/2025$48.00Overweight → Neutral
    Analyst
    6/9/2025$70.00Overweight
    Morgan Stanley
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Burdick Kenneth A claimed ownership of 360,802 shares (SEC Form 3)

    3/A - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:37:15 PM ET
    $CNC
    Medical Specialities
    Health Care

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    8/15/25 4:29:37 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    8/14/25 4:16:51 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    8/4/25 4:36:48 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CENTENE CORPORATION RECOMMENDS STOCKHOLDERS REJECT "MINI-TENDER" OFFER FROM TRC CAPITAL INVESTMENT CORPORATION

    ST. LOUIS, Aug. 20, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (Centene) announced today that it received notice of an unsolicited "mini-tender" offer from TRC Capital Investment Corporation (TRC) dated August 5th, 2025.  Centene is in no way affiliated with TRC. TRC has offered to purchase up to 4 million shares of Centene's common stock at $24.75 per share, and this offer expires on September 4th, 2025, subject to potential extension by TRC.  This is below the current market price of Centene's common stock.  Centene recommends stockholders reject TRC's offer and urges investors to assess the current market price of their shares as well as consult with their financial advisors. Th

    8/20/25 5:56:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    MHS Serves Announces Recipients of $1.2 Million Investment in Youth Mental Health

    INDIANAPOLIS, Aug. 7, 2025 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE:CNC) company, is proud to announce the recipients of the most recent partnership opportunity from MHS Serves, a $12 million program focused on addressing health disparities across Indiana. Through a collaborative partnership with Indiana Minority Health Coalition (IMHC) and Black Onyx Management managing the program, MHS Serves strives to empower communities through partnerships and innovations focused on health access.

    8/7/25 9:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Superior HealthPlan Invests $18 Million in Over-the-counter Items in 5 Years for Texas Members

    The extra benefits are in addition to regular Medicaid and CHIP coverage, helping support low-income individuals and families. AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE:CNC), announced today it invested $18 million in over-the-counter (OTC) items, a Value-added Service (VAS), for members enrolled in either Medicaid or Children's Health Insurance Program (CHIP) from 2020 through 2024. Value-added Services are extra benefits that help provide additional support for low-income families and individuals across all 254 Texas counties.

    8/5/25 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00

    7/23/25 7:38:36 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by TD Cowen with a new price target

    TD Cowen downgraded Centene from Buy to Hold and set a new price target of $33.00

    7/21/25 8:26:59 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS

    -- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $             48,742 Premium and service revenues (in millions) $             42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $                (0.51) Adjusted diluted loss per share (1) $                (0.16) Total cash flow provided by operations (in millions) $              

    7/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    CALL MOVED TO 8AM ET ST. LOUIS, July 22, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 25, 2025, and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7878291 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, 

    7/22/25 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS

    -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

    4/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care